Patrick E. Beans Buys 2,500 Shares of National Research Co. (NASDAQ:NRC) Stock

National Research Co. (NASDAQ:NRC) major shareholder Patrick E. Beans acquired 2,500 shares of the firm’s stock in a transaction on Monday, May 12th. The shares were acquired at an average price of $13.59 per share, with a total value of $33,975.00. Following the completion of the transaction, the insider now directly owns 35,003 shares in the company, valued at approximately $475,690.77. This trade represents a 7.69% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

National Research Price Performance

NRC opened at $13.98 on Friday. The stock has a fifty day moving average price of $12.68 and a 200 day moving average price of $15.96. The company has a current ratio of 0.47, a quick ratio of 0.47 and a debt-to-equity ratio of 1.30. National Research Co. has a 1 year low of $9.76 and a 1 year high of $32.48. The stock has a market cap of $320.79 million, a price-to-earnings ratio of 13.31 and a beta of 0.34.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Monday, April 28th. The company reported $0.25 EPS for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%. The business had revenue of $33.55 million during the quarter.

National Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.48 annualized dividend and a dividend yield of 3.43%. National Research’s dividend payout ratio (DPR) is 46.60%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. boosted its holdings in National Research by 2,250.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company’s stock worth $27,000 after purchasing an additional 1,463 shares in the last quarter. Aviso Financial Inc. lifted its position in shares of National Research by 37.2% in the first quarter. Aviso Financial Inc. now owns 3,076 shares of the company’s stock worth $39,000 after buying an additional 834 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of National Research by 376.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,507 shares of the company’s stock worth $44,000 after acquiring an additional 1,981 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of National Research during the 4th quarter valued at about $50,000. Finally, Signaturefd LLC increased its holdings in shares of National Research by 613.3% during the 4th quarter. Signaturefd LLC now owns 4,173 shares of the company’s stock valued at $74,000 after acquiring an additional 3,588 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.